DrugNews.net
Latest News

Latest News

Monday, September 08, 2014

For the past several months, DrugNews has reported on growing concerns that power morcellator devices used in many hysterectomies could spread uterine cancer.

Since April, the FDA has launched an investigation and advised doctors of potential risks. The largest manufacturer of the devices has also stopped selling them for the time being.

Read More >

Wednesday, September 03, 2014

Prior to losing its patent protection on January 1, 2014, the antidepressant drug Cymbalta was the top-selling drug for pharmaceutical giant Eli Lilly. Now, the company is facing a growing number of lawsuits claiming the medication caused debilitating withdrawal side effects.

Last month, lawyers representing former Cymbalta users around the country asked a federal judicial panel to move all cases to one central court for more efficient handling. If granted, the move would create a Cymbalta multidistrict litigation (MDL) court where victims can share legal resources and pursue their individual suits.

Read More >

Thursday, August 28, 2014

So far, nearly 1,000 women have filed lawsuits over the popular IUD contraceptive Mirena after suffering serious uterus perforations that required surgery.

Now, a growing number of lawsuits over a different issue indicate the birth control insert from Bayer may have other dangers as well.

Read More >

Wednesday, August 27, 2014

Last month, German drug manufacturer Bayer released their latest financial reports showing sales of the once-leading birth control pill Yaz has slowed by more than 10% in the past year.

Hidden deep in those records was additional information showing the company has spent nearly $2 billion on settlements for those who have been hospitalized for blood clots issues like stroke, deep vein thrombosis or pulmonary embolism.

Read More >

Sunday, August 17, 2014

Last week, the Judicial Panel on Multidistrict Litigation released their latest report detailing how many lawsuits are pending for various defective products around the country. These range from auto recall cases to BP Oil Spill litigation.

One of the largest cases, however, involves the birth control pills Yaz and Yasmin. On the market since 2001, the drugs have been linked to deadly blood clots that can cause deep vein thrombosis and pulmonary embolism.

Read More >

Monday, August 11, 2014

DrugNews has uncovered an increasing number of reports linking the blood thinner Xarelto with severe internal bleeding episodes. Now, litigation is also on the rise against Bayer, the company that makes the drug.

The resource center has learned a new lawsuit filed last month in Vermont alleges a man who had only been taking Xarelto for 10 days died after experiencing an unreversable brain hemorrhage.

Read More >

Saturday, August 09, 2014

Last week, DrugNews reported on the latest figures showing Bayer has paid billions to settle lawsuits over blood clot side effects from its popular birth control pills Yaz, Yasmin, Ocella and Gianvi.

Now, financial reports from the company also show sales of the drugs have fallen over 11% in the past year. This could be due to continued warnings over Yaz safety, as well as competition from generics and other contraceptives.

Read More >

Thursday, August 07, 2014
Tags:    Mirena

Although the Mirena IUD from Bayer has grown substantially in popularity over the past decade, it has also been linked to a variety of side effects.

The FDA and surgeons have warned that the plastic device can tear into or through uterus tissue, in some cases requiring painful removal surgery. At present, nearly 1,000 women have filed lawsuits for these complications.

Read More >

Friday, August 01, 2014

In April, the American Medical Association shocked many when it published a study relating the blockbuster erectile dysfunction pill Viagra with the most dangerous type of skin cancer – melanoma.

The data came from a trial that followed more than 24,000 men around the age of 65. It found those who had used sildenafil, the chemical name for Viagra, were as much as 92% more likely to later develop melanoma.

Read More >

Friday, August 01, 2014

German pharmaceutical leader Bayer released their second quarter financial reports yesterday. Amid the lengthy analysis of sales, research and emerging market potential was a small section outlining the ongoing litigation the company faces over its birth control drugs.

Chief among the legal risks for Bayer are Yaz and Yasmin, which have been around for over a decade but just recently were linked to dangerous blood clot injuries and deaths.

Read More >

« prev 1 2 3 4 5 6 7 8 9 10 11 12 13 next »